Larisa Popovich, Director of the Institute for Health Economics at the Higher School of Economics, commented on the data published in The Lancet that re-vaccination in certain cases can lead to myocarditis or Guillain-Barré syndrome. In an interview with RBC, the specialist noted that at the moment there is not enough information on the basis of which it is possible to confidently associate re-vaccination with the listed diseases.
The specialist believes that the data indicated in the article should not be taken seriously, since it is not yet fully understood how the immune system works in coronavirus.
The same opinion is shared by the infectious disease specialist, Doctor of Medical Sciences Nikolai Malyshev. He believes that the problem needs to be carefully studied. “Numerous studies are being carried out, on the basis of which the time period in which it is optimal to do revaccination is deduced. It is premature to worry, ringing the bells is not worth it – you need to study, ”he said.
Earlier, the medical journal The Lancet published an article about the futility of mass revaccination. It was sponsored by a group of scientists, including representatives of the World Health Organization and the United States Food and Drug Administration. According to experts, there is no need for re-vaccination yet, since the existing vaccines are sufficiently effective. In addition, too frequent or premature administration of repeated doses can lead to myocarditis and Guillain-Barré syndrome. However, for people with weak immune systems, revaccination may be beneficial.